Developer docs
API playgroundTry for free, no card

Search company profiles

TTP Group

Full company profile

uuid000c682

Namestring
TTP Group
Legal namestring
TTP Group Limited
Websiteurl
ttpgroup.com
Company typeenum
Private
Founded yearint
1987
Descriptiontext

TTP Group, established in 1987 and headquartered at Melbourn Science Park near Cambridge, UK, is a privately-held technology and product development company that incubates and spins out new technology businesses. The group employs 251-500 staff, including over 250 scientists and engineers, and operates three principal units: TTP plc (technology and product development consulting serving enterprise clients across healthcare, life sciences, communications, defense, and industrials), Awerian (a defense R&D subsidiary serving the UK and its allies, formed in September 2021), and Cellular Origins (a cell and gene therapy manufacturing automation company, introduced in January 2023). Since its founding, the group has created over 20 spin-out businesses.

TTP Group's business model combines professional services (technology and product development consulting delivered through TTP plc and Awerian) with technology incubation and exits. The group develops proprietary technologies internally, then either commercializes them directly with clients or forms dedicated spin-out companies that pursue independent growth, often culminating in acquisition by larger industry players. Notable proprietary technologies include the second-generation Disc Pump micropump platform, Vortex-Actuated Cell Sorting (VACS) technology, the Constellation robotic automation platform for cell therapy manufacturing, and ultra-fast thermocycling (commercialized as the VELO point-of-care PCR system). Recent high-value exits include LEX Diagnostics to QuidelOrtho for approximately US$100 million (April 2026) and Cellular Highways to STEMCELL Technologies (June 2025).

TTP Group became 100% employee-owned via an Employee Ownership Trust in December 2021, a structure described as one of the largest EOT transactions in the UK by deal value. Revenue is generated through consulting fees from client engagements, milestone-based development work, equity stakes retained in spin-out companies, and exit proceeds when spin-outs are acquired. The company's go-to-market is enterprise-direct, with deep collaborative partnerships rather than transactional sales. Customers span large global corporates in healthcare, life sciences, and defense, as well as government and allied defense customers via Awerian, with pricing operating on a quote-based engagement model with no publicly disclosed standard rates.

Short descriptiontext

TTP Group is a Cambridge, UK-based technology development and incubation company employing 250+ scientists and engineers to build proprietary deep-tech IP, spin out new businesses, and provide product development consulting to enterprise clients across healthcare, life sciences, defense, and industrials.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersRoyston, United Kingdom
HQ citystring
Royston
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
technology product development, contract research services, technology incubation, cell therapy manufacturing, defense research development
Industry1 code
1DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA)
CodeHLACANANPrimaryYes
NAICS code3 codes
  • Management Consulting Services54161
  • Computer Systems Design and Related Services54151
  • Custom Computer Programming Services541511
SIC code4 codes
  • Services-Computer Integrated Systems Design7373
  • Services-Computer Programming Services7371
  • Services-Management Consulting Services8742
  • Services-Engineering, Accounting, Research, Management8700
Product category
Technology and Product Development Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Technology Development and Consulting Services
TypeProfessional Services
Description

TTP Group operates as a technology and product development company, working closely with clients to bring new products to market. The company provides scientific and engineering expertise to help clients develop new technologies and products.

ttpgroup.com
2Technology Incubation and Spin-outs
TypeLicensing Royalties
Description

TTP Group creates and incubates new technology businesses, investing in early-stage technology companies. Revenue is generated through successful exits when spin-out companies are acquired or go public.

ttpgroup.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

TTP Group is a UK-based technology and product development company that provides scientific and engineering consulting services to bring new products to market for clients across healthcare, life sciences, communications, defense, and industrials. Beyond client services, TTP Group operates an innovation incubator that develops proprietary technologies internally and spins them out as standalone companies, with more than 20 businesses created since 1987. Active subsidiaries include TTP plc (core technology consulting), Awerian (defense R&D services for the UK and its allies), and Cellular Origins (cell and gene therapy manufacturing automation).

Differentiator
Functional benefit
Problem solved
Product overview1 text field

TTP Group is a technology and product development ecosystem comprising TTP plc (core technology consulting), Awerian (defense R&D), and multiple spin-out companies. The portfolio includes Cellular Origins (cell and gene therapy manufacturing automation with Constellation platform), alongside former spin-outs LEX Diagnostics (VELO molecular diagnostics system - acquired by QuidelOrtho 2026), Cellular Highways (Highway1 cell sorter using VACS technology - acquired by STEMCELL Technologies 2025), and TTP Ventus (Disc Pump micropumps - acquired by The Lee Company 2022). The group operates an Employee Ownership Trust model and has created over 20 new businesses since 1987.

Product and service3 records
1TTP plc technology and product development services
CategoryTechnology consulting services
Description

Technology and product development consulting that works closely with clients to bring new products to market and creates new business opportunities from advances in technology across healthcare, life sciences, communications, and industrials sectors.

2Awerian defence research and development services
CategoryDefence research and development services
Description

Research and development services for the UK Ministry of Defence and allied nations, operating collaboratively or stand-alone to address defence and security project needs.

3Cellular Origins Constellation robotic automation platform
CategoryCell and gene therapy manufacturing automation
Description

Enables scalable, reproducible, and efficient manufacture of cell and gene therapies by providing therapeutic developers and CDMOs with the Constellation platform for automated sterile fluidic interconnection that integrates existing workflows and instrumentation with future process innovation.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierFlagshipTypeOthersAnnounced on2026-04-21
Description

Nasdaq-listed in vitro diagnostics firm that acquired LEX Diagnostics from TTP Group for approximately US$100 million. LEX Diagnostics developed the VELO system for rapid PCR testing.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-09
Description

Strategic partnership for cell and gene therapy manufacturing. Cytiva is one of Cellular Origins' strategic partners supporting the integration and deployment of the Constellation platform for advanced therapy manufacturing.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-09
Description

Strategic partnership for cell and gene therapy manufacturing. Fresenius Kabi is one of Cellular Origins' strategic partners with existing relationships in place to support manufacturing scale-up.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-09
Description

Strategic partnership for cell and gene therapy manufacturing. Thermo Fisher Scientific is one of Cellular Origins' strategic partners supporting manufacturing infrastructure development.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-09
Description

Strategic partnership for cell and gene therapy manufacturing. Wilson Wolf is one of Cellular Origins' strategic partners supporting G-Rex platform integration.

Strategic tierFlagshipTypeOthersAnnounced on2025-06-02
Description

Acquired Cellular Highways from TTP Group, including the Highway1 instrument using VACS technology. STEMCELL is Canada's largest biotechnology company supporting life sciences research.

Strategic tierFlagshipTypeOthersAnnounced on2022-09-12
Description

Acquired TTP Ventus Limited from TTP Group. The Lee Company is a US-based company specializing in miniature fluid control components, and renamed the acquired entity Lee Ventus.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cambridge-headquartered deep-tech product development consultancy with very similar DNA to TTP plc: world-class engineering teams, multi-domain expertise, and a track record of incubating breakthrough technologies. Both firms compete for the same enterprise R&D mandates and spin-out talent in the Cambridge cluster.

TypeDirect peer
Description

UK-based science and technology product development consultancy (part of Science Group) operating in medical, industrial, and consumer sectors. Closely comparable to TTP plc in service offering, sector mix, and contract-based innovation model.

TypeBroad incumbent
Description

Global consulting firm with a sizable innovation and product development practice. Overlaps with TTP on deep-tech R&D, medtech, and defense but is far broader in scope (strategy, digital, operations), making it a broad incumbent rather than a direct specialist competitor.

TypeBroad incumbent
Description

US-based nonprofit R&D organization managing large-scale applied science, technology development, and commercialization programs. Comparable in its 'science-to-product' ethos and government/enterprise client base to TTP/Awerian, but operating at much larger scale.

TypeBroad incumbent
Description

Nonprofit scientific research institute with a long history of spinning out ventures (Sirius XM, Siri, etc.). Highly comparable in incubation model and multi-domain R&D, though more US-government and defense oriented, and significantly larger than TTP.

TypeDirect peer
Description

Medical device and digital health product development consultancy. Closely comparable to TTP's life-sciences spin-out DNA (LEX Diagnostics, Cellular Origins, Cellular Highways) with similar end-to-end design, engineering, and regulatory translation capabilities.

TypeDirect peer
Description

Canadian medical device design, development, and contract manufacturing firm. Directly comparable to TTP plc's medical-device and diagnostics product development work, with similar client base and regulatory translation focus.

TypeDirect peer
Description

UK-based science and engineering consultancy serving defense, national security, and commercial markets. Directly comparable to TTP's Awerian subsidiary in terms of client base, R&D services model, and UK defense/Allied nation positioning.

TypeBroad incumbent
Description

Global industrial automation and pneumatic technology company with a strong innovation/R&D arm. Comparable to TTP Group as a broad industrial-tech incumbent, though much larger and focused on automation components rather than bespoke product development and spin-outs.

TypeDirect peer
Description

UK-based technology design and innovation consultancy working across defense, medical, and industrial sectors. Comparable to TTP plc in engineering services depth, UK footprint, and enterprise/spin-out business mix.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TTP Group

Technology and Product Development Servicesttpgroup.com

TTP Group is a Cambridge, UK-based technology development and incubation company employing 250+ scientists and engineers to build proprietary deep-tech IP, spin out new businesses, and provide product development consulting to enterprise clients across healthcare, life sciences, defense, and industrials.

What TTP Group does

TTP Group, established in 1987 and headquartered at Melbourn Science Park near Cambridge, UK, is a privately-held technology and product development company that incubates and spins out new technology businesses. The group employs 251-500 staff, including over 250 scientists and engineers, and operates three principal units: TTP plc (technology and product development consulting serving enterprise clients across healthcare, life sciences, communications, defense, and industrials), Awerian (a defense R&D subsidiary serving the UK and its allies, formed in September 2021), and Cellular Origins (a cell and gene therapy manufacturing automation company, introduced in January 2023). Since its founding, the group has created over 20 spin-out businesses.

TTP Group's business model combines professional services (technology and product development consulting delivered through TTP plc and Awerian) with technology incubation and exits. The group develops proprietary technologies internally, then either commercializes them directly with clients or forms dedicated spin-out companies that pursue independent growth, often culminating in acquisition by larger industry players. Notable proprietary technologies include the second-generation Disc Pump micropump platform, Vortex-Actuated Cell Sorting (VACS) technology, the Constellation robotic automation platform for cell therapy manufacturing, and ultra-fast thermocycling (commercialized as the VELO point-of-care PCR system). Recent high-value exits include LEX Diagnostics to QuidelOrtho for approximately US$100 million (April 2026) and Cellular Highways to STEMCELL Technologies (June 2025).

TTP Group became 100% employee-owned via an Employee Ownership Trust in December 2021, a structure described as one of the largest EOT transactions in the UK by deal value. Revenue is generated through consulting fees from client engagements, milestone-based development work, equity stakes retained in spin-out companies, and exit proceeds when spin-outs are acquired. The company's go-to-market is enterprise-direct, with deep collaborative partnerships rather than transactional sales. Customers span large global corporates in healthcare, life sciences, and defense, as well as government and allied defense customers via Awerian, with pricing operating on a quote-based engagement model with no publicly disclosed standard rates.

TTP Group firmographics

Firmographics
Name
TTP Group
Legal name
TTP Group Limited
Website
https://ttpgroup.com
Company type
Private
Founded year
1987
Operating status
Operating
Headcount range
251–500 employees
Short description
TTP Group is a Cambridge, UK-based technology development and incubation company employing 250+ scientists and engineers to build proprietary deep-tech IP, spin out new businesses, and provide product development consulting to enterprise clients across healthcare, life sciences, defense, and industrials.
Ownership category
akta.pro rank

TTP Group industry classification

Industry
Product category
Technology and Product Development Services
NAICS
Management Consulting Services (54161), Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)
SIC
Services-Computer Integrated Systems Design (7373), Services-Computer Programming Services (7371), Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)
akta.pro primary industry
DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA) (HLACANAN)

Keywords

  • Technology product development
  • Contract research services
  • Technology incubation
  • Cell therapy manufacturing
  • Defense research development

Where TTP Group is headquartered

Location

Headquarters

HQ city
Royston
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

TTP Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Technology Development and Consulting Services: TTP Group operates as a technology and product development company, working closely with clients to bring new products to market. The company provides scientific and engineering expertise to help clients develop new technologies and products.
  2. Technology Incubation and Spin-outs: TTP Group creates and incubates new technology businesses, investing in early-stage technology companies. Revenue is generated through successful exits when spin-out companies are acquired or go public.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

TTP Group product offering

Product offering

Core offering

TTP Group is a UK-based technology and product development company that provides scientific and engineering consulting services to bring new products to market for clients across healthcare, life sciences, communications, defense, and industrials. Beyond client services, TTP Group operates an innovation incubator that develops proprietary technologies internally and spins them out as standalone companies, with more than 20 businesses created since 1987. Active subsidiaries include TTP plc (core technology consulting), Awerian (defense R&D services for the UK and its allies), and Cellular Origins (cell and gene therapy manufacturing automation).

Product overview

TTP Group is a technology and product development ecosystem comprising TTP plc (core technology consulting), Awerian (defense R&D), and multiple spin-out companies. The portfolio includes Cellular Origins (cell and gene therapy manufacturing automation with Constellation platform), alongside former spin-outs LEX Diagnostics (VELO molecular diagnostics system - acquired by QuidelOrtho 2026), Cellular Highways (Highway1 cell sorter using VACS technology - acquired by STEMCELL Technologies 2025), and TTP Ventus (Disc Pump micropumps - acquired by The Lee Company 2022). The group operates an Employee Ownership Trust model and has created over 20 new businesses since 1987.

Differentiator

Problem solved

Functional benefit

Products and services

  • TTP plc technology and product development services Technology and product development consulting that works closely with clients to bring new products to market and creates new business opportunities from advances in technology across healthcare, life sciences, communications, and industrials sectors.
  • Awerian defence research and development services Research and development services for the UK Ministry of Defence and allied nations, operating collaboratively or stand-alone to address defence and security project needs.
  • Cellular Origins Constellation robotic automation platform Enables scalable, reproducible, and efficient manufacture of cell and gene therapies by providing therapeutic developers and CDMOs with the Constellation platform for automated sterile fluidic interconnection that integrates existing workflows and instrumentation with future process innovation.

Companies that use TTP Group

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

TTP Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

TTP Group partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered flagship and core.

  • QuidelOrtho CorporationflagshipOthers · 21 April 2026Nasdaq-listed in vitro diagnostics firm that acquired LEX Diagnostics from TTP Group for approximately US$100 million. LEX Diagnostics developed the VELO system for rapid PCR testing.
  • CytivacoreStrategic or Co-development Partner · 9 December 2025Strategic partnership for cell and gene therapy manufacturing. Cytiva is one of Cellular Origins' strategic partners supporting the integration and deployment of the Constellation platform for advanced therapy manufacturing.
  • Fresenius KabicoreStrategic or Co-development Partner · 9 December 2025Strategic partnership for cell and gene therapy manufacturing. Fresenius Kabi is one of Cellular Origins' strategic partners with existing relationships in place to support manufacturing scale-up.
  • Thermo Fisher ScientificcoreStrategic or Co-development Partner · 9 December 2025Strategic partnership for cell and gene therapy manufacturing. Thermo Fisher Scientific is one of Cellular Origins' strategic partners supporting manufacturing infrastructure development.
  • Wilson WolfcoreStrategic or Co-development Partner · 9 December 2025Strategic partnership for cell and gene therapy manufacturing. Wilson Wolf is one of Cellular Origins' strategic partners supporting G-Rex platform integration.
  • STEMCELL TechnologiesflagshipOthers · 2 June 2025Acquired Cellular Highways from TTP Group, including the Highway1 instrument using VACS technology. STEMCELL is Canada's largest biotechnology company supporting life sciences research.
  • The Lee CompanyflagshipOthers · 12 September 2022Acquired TTP Ventus Limited from TTP Group. The Lee Company is a US-based company specializing in miniature fluid control components, and renamed the acquired entity Lee Ventus.

Scale indicators5 records

Recent moves12 records

Expansion highlights6 records

TTP Group competitors and assessment

Company assessment

Direct peers

  • Cambridge Consultants: Cambridge-headquartered deep-tech product development consultancy with very similar DNA to TTP plc: world-class engineering teams, multi-domain expertise, and a track record of incubating breakthrough technologies. Both firms compete for the same enterprise R&D mandates and spin-out talent in the Cambridge cluster.
  • Sagentia Innovation: UK-based science and technology product development consultancy (part of Science Group) operating in medical, industrial, and consumer sectors. Closely comparable to TTP plc in service offering, sector mix, and contract-based innovation model.
  • Ximedica: Medical device and digital health product development consultancy. Closely comparable to TTP's life-sciences spin-out DNA (LEX Diagnostics, Cellular Origins, Cellular Highways) with similar end-to-end design, engineering, and regulatory translation capabilities.
  • StarFish Medical: Canadian medical device design, development, and contract manufacturing firm. Directly comparable to TTP plc's medical-device and diagnostics product development work, with similar client base and regulatory translation focus.
  • Roke Manor Research (Roke): UK-based science and engineering consultancy serving defense, national security, and commercial markets. Directly comparable to TTP's Awerian subsidiary in terms of client base, R&D services model, and UK defense/Allied nation positioning.
  • Plextek: UK-based technology design and innovation consultancy working across defense, medical, and industrial sectors. Comparable to TTP plc in engineering services depth, UK footprint, and enterprise/spin-out business mix.

Broad incumbents

  • PA Consulting: Global consulting firm with a sizable innovation and product development practice. Overlaps with TTP on deep-tech R&D, medtech, and defense but is far broader in scope (strategy, digital, operations), making it a broad incumbent rather than a direct specialist competitor.
  • Battelle: US-based nonprofit R&D organization managing large-scale applied science, technology development, and commercialization programs. Comparable in its 'science-to-product' ethos and government/enterprise client base to TTP/Awerian, but operating at much larger scale.
  • SRI International: Nonprofit scientific research institute with a long history of spinning out ventures (Sirius XM, Siri, etc.). Highly comparable in incubation model and multi-domain R&D, though more US-government and defense oriented, and significantly larger than TTP.
  • Festo: Global industrial automation and pneumatic technology company with a strong innovation/R&D arm. Comparable to TTP Group as a broad industrial-tech incumbent, though much larger and focused on automation components rather than bespoke product development and spin-outs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

TTP Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TTP Group leadership team

Management profile

Number of profiles

Profiles5 records

TTP Group subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

TTP Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TTP Group M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TTP Group

What does TTP Group do?

TTP Group is a UK-based technology and product development company that provides scientific and engineering consulting services to bring new products to market for clients across healthcare, life sciences, communications, defense, and industrials. Beyond client services, TTP Group operates an innovation incubator that develops proprietary technologies internally and spins them out as standalone companies, with more than 20 businesses created since 1987. Active subsidiaries include TTP plc (core technology consulting), Awerian (defense R&D services for the UK and its allies), and Cellular Origins (cell and gene therapy manufacturing automation).

Is TTP Group a public or private company?

TTP Group is a private company. It is classified as management employee owned and is currently operating.

When was TTP Group founded?

TTP Group was founded in 1987. It employs 251 to 500 people.

Where is TTP Group based?

TTP Group is headquartered in Royston, United Kingdom, in the Europe region.

How does TTP Group make money?

Two revenue lines are on record. Technology Development and Consulting Services are the primary driver. The others are technology Incubation and Spin-outs.

Who are TTP Group's main competitors?

Direct peers on record are Cambridge Consultants, Sagentia Innovation, Ximedica, StarFish Medical, Roke Manor Research (Roke) and Plextek. Broad incumbents are PA Consulting, Battelle, SRI International and Festo.

Does TTP Group have an API?

No public API is recorded for TTP Group.

What industry is TTP Group in?

TTP Group's product category is Technology and Product Development Services. Its primary akta.pro industry code is HLACANAN, DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA). Its NAICS code is 54161 and its SIC code is 7373.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InvestorsinhealthcareUK: QuidelOrtho aquires LEX Diagnostics from TTP Group for US$100mQuidelOrtho, a Nasdaq-listed in vitro diagnostics firm, has acquired UK-based molecular diagnostics company LEX Diagnostics from TTP Group for approximately US$100 million.Business Wire BlogTTP Group Announces the Sale of LEX DiagnosticsTTP Group announced the acquisition by QuidelOrtho Corporation of LEX Diagnostics Limited, a UK-based molecular diagnostics spin-out that originated from TTP's innovation programme. LEX Diagnostics developed the VELO system, a point-of-care molecular testing platform that received U.S. FDA 510(k) clearance and CLIA waived status in February 2026 for rapid PCR testing of Flu A, Flu B, and COVID-19 with results available in 6-10 minutes. The acquisition represents a successful exit for TTP Group's model of incubating technologies and spinning out companies, while expanding QuidelOrtho's diagnostics portfolio.TtpgroupCellular Origins, a company created and incubated by TTP Group, raises USD 40 million in oversubscribed Series A roundCellular Origins, a spin-out from TTP Group focused on enabling large-scale manufacture of advanced therapies, has closed an oversubscribed Series A financing round raising USD 40 million. The funding will support expansion of the company's commercial team, broadening of unit operations within its modular manufacturing platform, and global scaling efforts. The round is presented as validation of TTP Group's track record in building and incubating ventures that develop breakthrough technologies in the life sciences sector.